With regard to the Opioid comments in the different conversations and presentations with SI, I am wondering on the possible impact or potential pathways which may open up for the CLBP indication and approval process. Does anyone have thoughts or insights into the importance of these comments?
D#
banter and General Discussion, page-10734
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.47 |
Change
-0.040(2.65%) |
Mkt cap ! $1.667B | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.50 | $1.45 | $4.492M | 3.061M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 50184 | $1.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.47 | 59337 | 14 |
View Market Depth
| Last trade - 12.46pm 08/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |